<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04012034</url>
  </required_header>
  <id_info>
    <org_study_id>RFDP</org_study_id>
    <nct_id>NCT04012034</nct_id>
  </id_info>
  <brief_title>Treatment With Radiofrequency in Patients With Chronic Pelvic Pain and History of Endometriosis</brief_title>
  <official_title>Treatment With Punction and Radiofrequency of Active Trigger Points in Patients With Pelvic Chronic Pain and History of Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Managing chronic pelvic pain in patients with a past history of endometriosis might be a
      challenge for the gynaecologist.

      The objective of this study is to evaluate pelvic pain after treatment with radiofrequency in
      patients with chronic pelvic pain and surgery for endometriosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with pelvic chronic pain and a past history of endometriosis without imaging
      evidence of endometriosis in the present will be enrolled in this study. The main objective
      of this study is to evaluate improvement of pelvic pain these patients. Moreover, quality of
      life and sexual function will be also assessed. Patients who are enrolled will come once a
      week per eight weeks to the hospital to have 30 minutes treatment with radiofrequency. They
      will be randomised in two groups, one receiving the radiofrequency and the other not (the
      device will be not give the energy). At the enrollement visit, the SF-36, VAS score, anxiety
      and depression tests and sexual function tests will be answered the patients. At the end of
      the treatment, and one month after the end, they will answer the same questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2019</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain: VAS score</measure>
    <time_frame>Baseline (Before starting the study)</time_frame>
    <description>Visual Analogue Scale Score, from 0 to 10, where 0 is no pain at all and 10 is the worst pain ever.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain: VAS score</measure>
    <time_frame>1 month after study completion</time_frame>
    <description>Visual Analogue Scale Score, from 0 to 10, where 0 is no pain at all and 10 is the worst pain ever.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life: QoL SF-36</measure>
    <time_frame>Before starting the study</time_frame>
    <description>QoL SF-36, scale where 0 is maximum disability and a score of 100 is equivalent to no disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life: QoL SF-36</measure>
    <time_frame>1 month after study completion</time_frame>
    <description>QoL SF-36, scale where 0 is maximum disability and a score of 100 is equivalent to no disability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Female Sexual Function Index (FSFI)</measure>
    <time_frame>Before starting the study</time_frame>
    <description>Female Sexual Function Index (FSFI), minimum score is 2 and maximum score is 36, meaning no disfunction at all</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Female Sexual Function Index (FSFI)</measure>
    <time_frame>1 month after study completion</time_frame>
    <description>Female Sexual Function Index (FSFI), minimum score is 2 and maximum score is 36, meaning no disfunction at all</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Endometriosis</condition>
  <condition>Chronic Pain</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Radiofrequency A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with radiofrequency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Treatment with radiofrequency without energy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiofrequency A</intervention_name>
    <description>Application of radiofrequency for 30 minutes per week during 8 weeks</description>
    <arm_group_label>Radiofrequency A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiofrequency B</intervention_name>
    <description>Application of radiofrequency without energy for 30 minutes per week during 8 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic pelvic pain

          -  Past surgery for endometriosis

        Exclusion Criteria:

          -  Active endometriosis, diagnosed by imaging techniques

          -  Presence of other diseases that can cause chronic pelvic pain

          -  Contraindication for the radiofrequency use: pregnancy, metallic prothesis
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francisco Carmona, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clinic of Barcelona</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mariona Rius, MD</last_name>
    <phone>0034932275534</phone>
    <email>marius@clinic.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Carmona, PhD</last_name>
      <phone>34-93-227-5436</phone>
      <email>fcarmona@clinic.ub.es</email>
    </contact>
    <investigator>
      <last_name>Francisco Carmona, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Carmona</last_name>
      <phone>932275436</phone>
      <email>fcarmona@clinic.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 25, 2019</study_first_submitted>
  <study_first_submitted_qc>July 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Francisco Carmona</investigator_full_name>
    <investigator_title>Head of gynecology department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>It is not intended to share IPD to other researchers since it is the first study of this kind in our setting.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

